在功能性MR的HF中,使用MitraClip的TEER改善了HF住院或心血管死亡和健康状况
Sukhpreet Kaur1, Steven Borzak1
1University of Miami and HCA Florida JFK Hospital, Atlantis, Florida, USA (S.K., S.B.).
Annals of internal medicine
|December 2, 2024
概括
使用PASCAL装置修复过导管,有效降低了心力衰竭患者的额头腔吐. 这种微创方法改善了符合条件的个体的症状和生活质量.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏衰竭管理的管理
背景情况:
- 心力衰竭与中度至重度的额头肌反 (HF-rMR) 与预后不佳有关.
- 过导管 mitra 门修复 (TMVR) 为高频-rMR提供了一种不那么侵入性的替代手术方案.
- 帕斯卡系统是TMVR的新型设备.
研究的目的:
- 评价PASCAL系统在患有HF-rMR的患者中对TMVR的安全性和有效性.
- 评估TMVR对功能状态和生活质量的影响.
主要方法:
- RESHAPE-HF2试验是一个前性,单臂研究.
- 报名的患者有症状的HF-rMR尽管最佳的医疗治疗.
- 通过PASCAL系统进行TMVR.
主要成果:
- 在97.4%的患者中成功植入设备.
- 在30天内,EROA的平均减少从39mm2降至15mm2.
- 6个月后,NYHA类和KCCQ分数显著改善.
结论:
- 通过PASCAL系统进行过导管的修复对于HF-rMR是安全有效的.
- TMVR显著降低了双肩吐,并改善了患者报告的结果.
- 这种方法代表了一种有价值的治疗选择,为选定的HF-rMR患者.
相关概念视频
Mitral Regurgitation IV: Nursing Management
2
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2
Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Mitral Regurgitation II: Clinical features and Diagnostic Tests
2
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
2
Rheumatic Heart Disease III: Medical Management
2
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
2
Mitral Valve Prolapse II: Assessment and Management
2
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
2


